Sebastian Barnutz’s Post

In a Fireside Chat during the 2024 JP Morgan Healthcare Conference, Alessandro Maselli, Catalent's President & CEO shared his 6 predictions for biotech for 2024. He gives his thoughts on the top risks and opportunities in Biotech. View the session here: https://ow.ly/743450QARtH

In a Fireside Chat during the 2024 JP Morgan Healthcare Conference, Alessandro Maselli, Catalent's President & CEO shared his 6 predictions for biotech for 2024. He gives his thoughts on the top risks and opportunities in Biotech. View the session here: https://ow.ly/743450QARtH

🌟We’re thrilled to announce that SAI MedPartners will be attending the Pharma CI Conference!🌟 This event is a hub of innovation, insights, and industry leaders—all coming together to shape the future of competitive intelligence in pharma and biotech. Whether it's exploring new strategies, sharing our expertise, or simply connecting with like-minded professionals, we're excited to dive in and be part of the conversation. Let’s connect, collaborate, and create the future of pharma intelligence together! See you there! 👋 #PharmaCI #CompetitiveIntelligence #SAIMedPartners #PharmaInnovation

𝙄𝙣𝙩𝙧𝙤𝙙𝙪𝙘𝙞𝙣𝙜 𝙩𝙝𝙚 𝙄𝙣𝙖𝙪𝙜𝙪𝙧𝙖𝙡 𝙋𝙤𝙧𝙩𝙛𝙤𝙡𝙞𝙤 𝙎𝙩𝙧𝙖𝙩𝙚𝙜𝙮 & 𝘿𝙚𝙘𝙞𝙨𝙞𝙤𝙣 𝙈𝙖𝙠𝙞𝙣𝙜 𝙛𝙤𝙧 𝘽𝙞𝙤𝙥𝙝𝙖𝙧𝙢𝙖 𝙎𝙪𝙢𝙢𝙞𝙩! Join us in Boston, MA, this November 20-21 for a transformative event tailored for leaders in portfolio strategy within the biopharma industry. This summit offers a unique opportunity to connect with over 60 leaders from top pharma and biotech companies, all focused on enhancing portfolio strategies. You'll gain expert insights, forge valuable partnerships, and foster cross-functional collaboration in an intimate setting designed for impactful networking. In today's rapidly evolving biopharma landscape, staying ahead is more critical than ever. By attending, you'll equip yourself to make informed decisions, mitigate risks, align stakeholders, and drive sustainable portfolio growth. Don't miss out on this essential event to navigate the challenges and seize the opportunities in the biopharma market. Download the newly released event guide today to explore the comprehensive agenda and 19+ world-class speakers joining us: https://ter.li/7b0sum #DecisionMaking #Biopharma #BioPharmaSummit #PortfolioStrategy #PharmaLeadership #StrategicDecisions #BiopharmaInnovation #CrossFunctionalCollaboration

Join us at #DPEast for the panel "Restructuring Again? Redefine Skills, Capabilities, and Operating Models to Build a Sustainable, Successful Marketing Framework for the Future." REGISTER NOW! Don't miss out on this session: https://ow.ly/7M9C50SOmEU 💡What to Expect: 👉Examine the shift from linear to more collaborative, cross-stakeholder processes throughout the entire marketing lifecycle 👉Explore the evolving structure of pharma companies and strategies for staying agile and adapting to change management to foster growth 👉Who will be the decision-makers and how will decisions be made under these new operating models? 👉How does the changing pharma framework impact agency/solution provider and pharma relationship? Check out more Featured Sessions: https://ow.ly/rffB50SOmg6 A big thank you to our Moderators & Speakers for this Panel: - Robert (Bob) Allen from Bristol Myers Squibb - Kate Greengrove from GSK - Brian Cantwell from Bayer - Annemarie Carpico Jazz Pharmaceuticals (EUSA Pharma USA) Inc. - Kara Reheis from Daiichi Sankyo Stay Updated by following Fierce Life Sciences Events & Digital Pharma Series #DigitalPharma #PharmaMarketing #PharmaLeadership #HealthcareStrategies #WeAreFierce #FierceBiotech #FierceHealth #FiercePharma

At #futurepharma, we give you everything you need to make the most of your 10+ hours of dedicated networking time with decision makers ready to invest in your solution. How else can your company stand to benefit by sponsoring Future Pharma 2024? Learn more here: https://bit.ly/3Zncx3Q #digitalhealth #healthcareinnovation

What if we could revolutionize healthcare by truly putting patients first? At the upcoming Fierce Digital Pharma East Conference on September 12th, I'll be diving into exactly that. In my session, "Expanding Pharma Innovation: Harnessing Design Thinking for Patient-Centric Solutions," I’ll share insights from a couple of decades in the pharmaceutical industry, focusing on the transformative potential of design thinking. This approach, not used enough pharma, is more than just a buzzword—it's about empathy, innovation, and a commitment to developing solutions that genuinely resonate with our audiences. I’ll be presenting practical examples and case studies that highlight how adopting an agile mindset in design thinking can elevate patient care and drive sustainable business growth. It's an opportunity to reimagine how we approach healthcare and ensure that innovation truly benefits those it’s meant to serve. By prioritizing patients in every decision, we have the power to drive meaningful change and make a lasting impact on the industry. Hope to see you there! #DesignThinking #PharmaInnovation #PatientCentricCare #AgileMindset #Leadership #DigitalPharmaEast https://lnkd.in/eJniPFTv

We are very much looking forward to getting the community back together this fall for #ExecutiveDecisionMaking 2024. Review the newly release preliminary agendas and take advantage of early savings and secure your spot to join seasoned bio pharma strategic and operational leaders to delve into new approaches and share best practices. #portfoliomanagement #resourcemanagement

Fierce Pharma had an excellent session with Murray Aitken and Anthony Mikulaschek from IQVIA discussing market trends in funding, spending, trial starts, and white space in #clinicaltrials. The white space between phases presents a great opportunity for us to decrease time to market. I've long believed that the future lies in rolling protocols. What strategies do you think can help shorten decision-making and administrative delays? #innovation #clinicalresearch #innovateinwhatyoudo

This month we are pleased to share an interview published in the The Irish Times as part of our commitment to the Pharma Industry Awards, where we serve as 'Impact Ambassador for Digital Innovation.' The Q&A includes insights from David Sheedy, Head of Life Sciences Manufacturing Ireland, and David Staunton, Head of Transformation for Cognizant, and discusses the latest trends and challenges in pharma manufacturing. Our leaders highlight the critical role of digital innovation and technology in driving industry advancements, emphasizing the importance of a data-centric approach to improve the economics of drug manufacturing. The interview also explores the potential of hashtag#generativeAI to make personalized therapies more accessible and affordable, along with the factors contributing to genuine innovation in the field. Additionally, they discuss ongoing digital transformation in the industry, driven by technology integration, and offer a forward-looking perspective on the emerging technologies set to shape the next decade. Read the full interview here: https://cogniz.at/3BPplIr #digitalinnovation #pharmaindustryawards #irelandpharma